Delixy Holdings Limited financials

DLXY CIK 0002025218

Source: EDGAR filings · Built 2026-06-19T00:46:35Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2024FY 2024
EBITDA 774.00K 1.19M 286.00K
Working Capital 88.00K 4.99M 992.00K
Net Debt -1.78M -3.28M -8.20M
Gross Margin 0.83% 1.36% 1.43% 0.75%
Operating Margin -1.47% 0.22% 0.39% 0.07%
Net Margin -1.45% 0.33% 0.40% 0.08%
Return on Equity (ROE) -4250.48% 75.98% 63.12% 2.12%
Return on Assets (ROA) -17.93% 4.35% 11.03%
Current Ratio 1.00× 1.29× 1.12×
Debt-to-Equity 0.15× 0.04× 0.03×
Effective Tax Rate -3.14% 8.70% 16.34% 21.43%
Cash Conversion Ratio 1.18× 0.60× 3.52× -19.37×
Accruals Ratio 0.03× 0.02× -0.28×

Income Statement

Concept FY 2025FY 2024FY 2024FY 2024
Revenues 307.75M 314.92M 289.17M 319.80M
Cost of Revenue 305.20M 310.62M 285.04M 317.41M
Gross Profit 2.54M 4.30M 4.13M 2.40M
Operating Income (Loss) -4.53M 706.00K 1.12M 217.00K
Income Tax Expense (Benefit) 136.00K 98.00K 225.00K 69.00K
Net Income (Loss) Attributable to Parent -4.46M 1.03M 1.15M 253.00K
Earnings Per Share, Basic $-0.29 $0.07 $0.08 $0.02
Weighted Average Number of Shares Outstanding, Basic 15.65M 15.00M 15.00M 15.00M
Earnings Per Share, Diluted $-0.29 $0.07 $0.08 $0.02
Weighted Average Number of Shares Outstanding, Diluted 15.65M 15.00M 15.00M 15.00M

Balance Sheet

Concept FY 2025FY 2024FY 2024FY 2024
Cash and Cash Equivalents, at Carrying Value 1.79M 3.34M 8.24M
Assets, Current 24.87M 22.27M 9.60M
Assets 24.89M 23.66M 10.44M
Liabilities, Current 24.78M 17.29M 8.61M
Liabilities 24.78M 22.30M 8.62M
Stockholders' Equity Attributable to Parent 105.00K 1.35M 1.82M 11.91M

Cash Flow Statement

Concept FY 2025FY 2024FY 2024FY 2024
Net Cash Provided by (Used in) Operating Activities -5.25M 612.00K 4.05M -4.90M
Net Cash Provided by (Used in) Investing Activities 160.00K 552.00K -188.00K 2.69M
Payments of Dividends 4.75M 1.50M
Net Cash Provided by (Used in) Financing Activities 3.54M -6.07M -1.68M -458.00K

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (DLXY CIK 0002025218), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

MDV

MODIV INDUSTRIAL, INC.

TRLV

TRULIEVE CANNABIS CORP.

CRMD

CORMEDIX INC.